Czech-based CB21 Pharma said it has obtained approval for a CBD-infused suppository which will go on the market in pharmacies and online in February. The company said the product helps with healing after childbirth, gynecological procedures and chemotherapy. CB21 said it has plans to develop other products for dentistry and neurology in the coming years. Investments in the development, research and production of CB21 Pharma are financed by Czech billionaire Karel Janeček. The company received a certificate of good manufacturing practice for the production of CBD for pharmaceutical purposes last year.
CBD suppository to debut
Support HempToday with a donation
We appreciate our paying subscribers and strive to deliver the most complete, well-researched and comprehensive news, analysis and commentary about the hemp industries. If you’d like to further support us, click below to make a donation.